MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 04-04-2026
Insulet Corporation DSO Ratio 2011-2026 | PODD
Annual DSO Ratio Insulet Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | 40.7 | 30.9 | 32.8 | 37.8 | 32.3 | 28.6 | 54.5 | 50.4 | 48.8 | 57.5 | 55.6 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 57.5 | 28.6 | 42.7 |
Quarterly DSO Ratio Insulet Corporation
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | - | - | - | - | - | - | 44.6 | - | 35.5 | 34.4 | 34.9 | - | 32.7 | 33.8 | 35.3 | 30.2 | 32.9 | 35.7 | 37.9 | 35 | 38.2 | 46.5 | 43.1 | 37.3 | 40 | 44.4 | 36.9 | 25.4 | 27.7 | 30.1 | 40.1 | 46.3 | 54.4 | 64.1 | 73.7 | 58.7 | 48.5 | 50.5 | 48.1 | 44 | 49.4 | 50.2 | 52.8 | 52.5 | 55.5 | 59.5 | 54 | 44.8 | 47.5 | 65.7 | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 73.7 | 25.4 | 44.1 |
DSO Ratio of other stocks in the Medical devices industry
| Issuer | DSO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
GenMark Diagnostics, Inc.
GNMK
|
44.2 | - | - | $ 1.77 B |  USA |
 |
Acutus Medical
AFIB
|
746 | - | -26.83 % | $ 2.62 M | USA |
 |
Align Technology
ALGN
|
86.7 | $ 173.14 | -0.8 % | $ 13 B | USA |
 |
AdaptHealth Corp.
AHCO
|
43.8 | $ 12.17 | -0.41 % | $ 1.64 B | USA |
 |
Allied Healthcare Products
AHPI
|
161 | - | 3.58 % | $ 2.21 M | USA |
 |
Alphatec Holdings
ATEC
|
43.1 | $ 10.9 | -1.54 % | $ 1.64 B | USA |
 |
Lianluo Smart Limited
LLIT
|
215 | - | 24.59 % | $ 44.8 M |  China |
 |
Axonics Modulation Technologies
AXNX
|
49.2 | - | - | $ 3.31 B | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
724 | - | -5.86 % | $ 30.6 M | USA |
 |
Bio-Rad Laboratories
BIO
|
66.9 | $ 279.25 | 0.63 % | $ 7.88 B | USA |
 |
BioSig Technologies
BSGM
|
607 | - | 37.08 % | $ 85.7 M | USA |
 |
Conformis
CFMS
|
55.4 | - | - | $ 16.4 M | USA |
 |
EDAP TMS S.A.
EDAP
|
91.8 | $ 3.3 | -1.79 % | $ 124 M |  France |
 |
Bruker Corporation
BRKR
|
57.3 | $ 37.59 | -1.03 % | $ 5.6 K | USA |
 |
Boston Scientific Corporation
BSX
|
65.7 | $ 61.79 | 0.83 % | $ 91.5 B | USA |
 |
Apollo Endosurgery
APEN
|
59.5 | - | - | $ 475 M | USA |
 |
Cardiovascular Systems
CSII
|
61.6 | - | 0.15 % | $ 844 M | USA |
 |
Cytosorbents Corporation
CTSO
|
73.2 | $ 0.61 | 0.84 % | $ 38 M | USA |
 |
ClearPoint Neuro
CLPT
|
55.6 | $ 8.68 | -3.12 % | $ 246 M | USA |
 |
Dynatronics Corporation
DYNT
|
41.6 | - | 14.99 % | $ 929 K | USA |
 |
Electromed
ELMD
|
137 | $ 24.12 | -1.19 % | $ 204 M | USA |
 |
CryoLife, Inc.
CRY
|
70.3 | - | -4.14 % | $ 702 M | USA |
 |
Avinger
AVGR
|
49.4 | - | -20.74 % | $ 369 K | USA |
 |
Second Sight Medical Products
EYES
|
49.1 | - | -0.97 % | $ 54.4 M | USA |
 |
CHF Solutions, Inc.
CHFS
|
52.9 | - | 1.15 % | $ 34.5 M | USA |
 |
Aziyo Biologics
AZYO
|
59.5 | - | 1.37 % | $ 20.5 M | USA |
 |
Helius Medical Technologies
HSDT
|
53.3 | $ 1.89 | - | $ 1.15 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
62.7 | - | -1.98 % | $ 98.3 M | USA |
 |
GBS
GBS
|
61.2 | - | -0.57 % | $ 7.12 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
85.4 | - | 0.03 % | $ 1.58 B |  Israel |
 |
Misonix, Inc.
MSON
|
64.6 | - | - | $ 462 M | USA |
 |
Inogen
INGN
|
35.8 | $ 6.33 | -4.95 % | $ 168 M | USA |
 |
IRIDEX Corporation
IRIX
|
47.5 | $ 1.0 | -3.86 % | $ 16.9 M | USA |
 |
Neovasc
NVCN
|
120 | - | - | $ 111 M |  Canada |
 |
OrthoPediatrics Corp.
KIDS
|
74.3 | $ 15.97 | 0.19 % | $ 375 M | USA |
 |
Globus Medical
GMED
|
76.8 | $ 90.42 | -1.07 % | $ 12.2 B | USA |
 |
LivaNova PLC
LIVN
|
53.8 | $ 62.78 | -0.93 % | $ 3.42 B |  Britain |
 |
LENSAR
LNSR
|
38.9 | $ 5.7 | 4.4 % | $ 68.2 M | USA |
 |
Butterfly Network
BFLY
|
76.1 | $ 4.11 | -0.96 % | $ 870 M | USA |
 |
Intersect ENT, Inc.
XENT
|
66.1 | - | - | $ 955 M | USA |
 |
BIOLASE
BIOL
|
42 | - | -13.19 % | $ 166 K | USA |
 |
Delcath Systems
DCTH
|
48.5 | $ 10.04 | 1.62 % | $ 360 M | USA |
 |
Inspire Medical Systems
INSP
|
42.6 | $ 54.02 | -4.71 % | $ 1.59 B | USA |
 |
CONMED Corporation
CNMD
|
64.5 | $ 36.74 | -0.51 % | $ 1.14 B | USA |
 |
Myomo
MYO
|
35.3 | $ 0.69 | -1.43 % | $ 28.9 M | USA |
 |
NanoVibronix
NAOV
|
29.7 | - | - | $ 1.08 M | USA |
 |
Integer Holdings Corporation
ITGR
|
58.2 | $ 85.11 | -1.8 % | $ 2.96 B | USA |
 |
FONAR Corporation
FONR
|
237 | $ 18.68 | 0.38 % | $ 122 M | USA |
 |
Invacare Corporation
IVC
|
206 | - | - | $ 24.7 M | USA |